Antibiotic resistance and choice of antimicrobial agents for acute otitis media

Pediatric Annals

Volumn 31, Issue 12, 2002, Pages 794-799

  Barnett, Elizabeth D ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; BETA LACTAMASE; CEFTRIAXONE; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; KETOLIDE; LINEZOLID; OXAZOLIDINONE DERIVATIVE; PENICILLIN G; PNEUMOCOCCUS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; CHILD; CHILD CARE; CLINICAL FEATURE; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DRUG CHOICE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS INFLUENZAE; HUMAN; MEDICAL DECISION MAKING; OTITIS MEDIA; PALATABILITY; REVIEW; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0036904495     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20021201-08     Document Type: Review

References (27)

1. Rosenfield RM, Bertrees JE, Carr J, et al. Clinical efficacy of antimicrobial drugs for acute otitis media: Meta-analysis of 5400 children from thirty-three randomized trials. J Pediatr. 1994;124:355-367.
2. Howie VM. Otitis media. Pediatr Rev. 1993;14:320-323.
3. Appelbaum PC. Resistance among Streptococcus pneumoniae: Implications for drug selection. Clin Infect Dis. 2002;34:1613-1620.
4. Centers for Disease Control and Prevention. Geographic variation in penicillin resistance in Streptococcus pneumoniae-selected sites, United States, 1997. MMWR. 1999;48:656-661.
5. Jorgensen JH, Doern GV, Maher LA, et al. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumo pneunioniae in the United States. Antimicrob Agents Chemother. 1990;34:2075-2080.
6. Doern GV, Pfaller MA, Kugler K, et al. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 Results from the SENTRY Antimicrobial Surveillance Program. Clin Infect Dis. 1998;27:764-770.
7. Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother. 2001;45:1721-1729.
8. Jacobs MR, Bajaksouzian S, Zilles A, et al. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 Surveillance study. Antimicrob Agents Chemother. 1999;43:1901-1908.
9. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: Risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J. 1995;14:751-759.
10. Zenni MK, Cheatham SH, Thompson JM, et al. Streptococcus pneumoniae colonization in the young child: Association with otitis media and resistance to penicillin. J Pediatr. 1995;127:533-537.
11. Boken DJ, Chartrand SA, Goering RB, Kruger R, Harrison CJ. Colonization with penicillin-resistant Streptococcus pneumoniae in a child-care center. Pediatr Infect Dis J. 1995;14:879-884.
12. Friedland IR, McCracken GH Jr. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med. 1994;331:377-382.
13. Canafax DM, Yuan Z, Chonmaitree T, Deka K, Russlie HQ, Giebink GS. Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media. Pediatr Infect Dis J. 1998;17:149-156.
14. Hoban DJ, Doern GV, Fluit AC, Roussel-Delvallez M, Jones RN. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001;32(Suppl 2):S81-93.
15. Jones ME, Karlowskyh JA, Blosser-Middleton R, Critchley IA, Thornsberry C, Sahm DF. Apparent plateau in β-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: Results from the LIBRA Surveillance initiative. International Jour Antimicrob Agents. 2002;19:119-123.
16. Doern GV, Brueggemann AB, Peirce G, Holley HPG, Rauch A. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: Results of a national multicenter surveillance study. Antimicrob Agents Chemother. 1997;41:292-297.
17. Thornsberry C, Ogilvie P, Kahn J, Mauriz Y. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group. Diagn Microbiol Infect Dis. 1997;29:249-257.
18. Dagan R. Treatment of acute otitis media-challenges in the era of antibiotic resistance. Vaccine. 2001;19:S9-S16.
19. Baquero F, Loza E. Antibiotic resistance of microorganisms involved in ear, nose and throat infections. Pediatr Infect Dis J. 1994;13:S9-14.
20. Barnett ED, Klein JO. The problem of resistant bacteria for the management of acute otitis media. Pediatr Clin North Am. 1995;42:509-517.
21. Klein JO. Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr Infect Dis J. 1993;12:973-975.
22. Marchant CD, Carlin SA, Johnson CE, et al. Measuring the comparative efficacy of antibacterial agents for acute otitis media: The "Pollyanna phenomenon". J Pediatr. 1992;120:72-77.
23. Rosenfeld RM. An evidence-based approach to treating otitis media. Pediatr Clin North Am. 1996;43:1165-1181.
24. Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: Management and surveillance in an era of pneumococcal resistance - A report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J. 1999;18:1-9.
25. Klein JO. Clinical implications of antibiotic resistance for management of acute otitis media. Pediatr Infect Dis J. 1998;17:1084-1089.
26. Pichichero ME. Recurrent and persistent otitis media. Pediatr Infect Dis J. 2000;19:911-916.
27. Klein JO. Clinical implications of antibiotic resistance for management of acute otitis media. J Lab Clin Med. 2000;135:220-224.